Medical Patent News

RSS

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") announced today that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company's DCVax® therapeutic cancer vaccines.

4 Dec 2009

Smokefree Innotec's Swiss patent and trademark attorneys start nationalizing PCT patent application

Smokefree Innotec, Inc. announced today that its Swiss patent and trademark attorneys Spierenburg & Partners AG have started nationalizing and regionalizing the PCT patent application for SFIO's Real Smokefree product.

4 Dec 2009

Patent titled 'System and Method for 4D Reconstruction and Visualization' receives issuance in Japan

VirtualScopics, Inc., a leading provider of quantitative imaging for clinical trials, announced today that its patent titled "System and Method for 4D Reconstruction and Visualization" recently received issuance in Japan.

4 Dec 2009

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Non-Invasive Monitoring Systems, Inc. announced that the Canadian Patent Office issued Patent number 2,534,302 to NIMS on October 20, 2009. The patent, entitled “Reciprocating Movement Platform for the External Addition of Pulses to the Fluid Channels of a Subject”, relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform.

3 Dec 2009

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGIL® (armodafinil) Tablets [C-IV].

3 Dec 2009

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled “POU5-F1 Expression in Human Mesenchymal Stem Cells” and the development of new technology related to generation of human induced pluripotent stem cells (iPS).

2 Dec 2009

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440, titled "Cyclic Natriuretic Peptide Constructs." The claims in the issued patent cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate.

1 Dec 2009

Kemin Foods, OmniActive settle patent dispute

Kemin Foods, L.C. ("Kemin") and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached an amicable settlement of their dispute.

1 Dec 2009

European Patent Office grants patent EP1392642 for 4SC AG's lead auto-immune compound

4SC AG, a drug discovery and development company, today announced that the European Patent Office has granted patent EP1392642, which covers its lead auto-immune compound 4SC-101.

1 Dec 2009

USPTO issues Notice of Allowance for Titan Pharmaceuticals' Probuphine patent application

Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan’s United States patent application directed to the use of Probuphine for the treatment of opiate addiction.

1 Dec 2009

GLUMETZA patent infringement lawsuit against Lupin

Depomed, Inc. today announced that it has filed a lawsuit in the United States District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceuticals, Inc., for infringement of the patents listed in the Orange Book for GLUMETZA® (metformin hydrochloride extended release tablets).

30 Nov 2009

Applied Spine Technologies awarded U.S patent relating to mounting mechanisms for pedicle screws

Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, has been awarded a new patent titled "Mounting mechanisms for pedicle screws and related assemblies”.

30 Nov 2009

Allos Therapeutics granted U.S. patent for FOLOTYN

Allos Therapeutics, Inc. today announced that the United States Patent and Trademark Office has issued a patent for the use of FOLOTYN™ (pralatrexate injection) for the treatment of T-cell lymphoma. U.S. Patent No. 7,622,470 was issued to Memorial-Sloan Kettering Cancer Center, SRI International and Southern Research Institute, and expires on November 24, 2025.

30 Nov 2009

USPTO approves Acuo Technologies' patent application

ACUO TECHNOLOGIES, developers of high-performance medical image management software, data migration tools and services, is pleased to announce that the United States Patent and Trademark Office has approved a patent application for an "Asset Communication Format within a Computer Network."

28 Nov 2009

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.

25 Nov 2009

Filing of motion to discontinue all proceedings related to patent infringement lawsuit announced

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has filed a motion to stay, or discontinue all proceedings in, the patent infringement lawsuit brought against it in October 2009 by Cook, Inc.

25 Nov 2009

US Patent & Trademark Office allows patent application for NOD technology

NOD Pharmaceuticals Inc. announced the US Patent & Trademark Office (PTO) has allowed the patent application for its nano-particle oral delivery or NOD technology.

25 Nov 2009

Bioniche Life Sciences announces the issuance of MCC patents in Japan

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced the issuance of a number of patents in Japan for its proprietary Mycobacterial Cell Wall-DNA Complex (MCC) composition.

25 Nov 2009

DJO's new Moveo XP Rehabilitation Platform granted U.S. patent

DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that its Chattanooga division was issued U.S. Patent No. 7597656 for Chattanooga’s new Moveo XP Rehabilitation Platform. The Moveo XP is the first product of its kind, allowing patients who are incapable of supporting full body weight to participate in graded weight-bearing activity at an earlier stage in their physical rehabilitation.

24 Nov 2009

Cardio Vascular Medical Device to initiate patent applications for its "steerable guidewire" in Europe

Cardio Vascular Medical Device Corp., a leading developer of advanced cardiovascular surgery technology, today announced that the company's Board of Directors has decided to initiate patent applications in Europe, Canada and the Far East for its proprietary next-generation "steerable guidewire" applicable for all angioplasty (PCTA) procedures.

21 Nov 2009

Medical Patent News

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Smokefree Innotec's Swiss patent and trademark attorneys start nationalizing PCT patent application

Patent titled 'System and Method for 4D Reconstruction and Visualization' receives issuance in Japan

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

Kemin Foods, OmniActive settle patent dispute

European Patent Office grants patent EP1392642 for 4SC AG's lead auto-immune compound

USPTO issues Notice of Allowance for Titan Pharmaceuticals' Probuphine patent application

GLUMETZA patent infringement lawsuit against Lupin

Applied Spine Technologies awarded U.S patent relating to mounting mechanisms for pedicle screws

Allos Therapeutics granted U.S. patent for FOLOTYN

USPTO approves Acuo Technologies' patent application

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Filing of motion to discontinue all proceedings related to patent infringement lawsuit announced

US Patent & Trademark Office allows patent application for NOD technology

Bioniche Life Sciences announces the issuance of MCC patents in Japan

DJO's new Moveo XP Rehabilitation Platform granted U.S. patent

Cardio Vascular Medical Device to initiate patent applications for its "steerable guidewire" in Europe

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News